CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the use of adipose-derived mesenchymal stem cells to treat severe sepsis caused by lung infections. The aim is to restore immune balance and reduce organ damage in patients suffering from this life-threatening condition.
Sepsis is defined as a systemic inflammatory response to infection, while severe sepsis (SS) is a sepsis complicated by acute organ dysfunction.
Lung infections, in particular community-acquire pneumonia (CAP), are the leading cause of SS.
The pathophysiologic mechanism of CAP-mediated SS is the complete dysregulation of the patient´s immune system.
In an initial phase, the systemic hyperactivation of the host immune response against infection leads to high levels of inflammatory mediators, syst…
TIGENIX SA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL
Belgium, Bruxelles / Brussel
Type: Other
Activity type: Other
SME: No
Netherlands, Amsterdam
Type: Research institute
Activity type: Research Organisations
SME: No
Spain, MADRID
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
